Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 19:
20. The compound of claim 6, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C1-C5 alkyl, wherein the C1-C5 alkyl is substituted by 2, 3, 4, or 5 independently selected R2a substituents; and
each R2a is independently halogen, C1-C6 alkyl, NR5C(O)OR6, OR5, C3-C8 cycloalkyl, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein each C6-C14 aryl is optionally and independently substituted by 1 or more independently selected R4a substituents.